Paradigm Biocapital Advisors LP Portfolio Holdings

Paradigm Biocapital Advisors LP

  • $2.67 Billion
  • Q1 2024

Paradigm Biocapital Advisors LP has filed its 13F form on May 15, 2024 for Q1 2024 where it was disclosed a total value porftolio of $2.67 Billion distributed in 34 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Nuvalent, Inc. with a value of $314M, Arcellx, Inc. with a value of $266M, Argenx Se with a value of $217M, Crinetics Pharmaceuticals, Inc. with a value of $146M, and Sarepta Therapeutics, Inc. with a value of $140M.

Examining the 13F form we can see an increase of $740M in the current position value, from $1.93B to 2.67B.

Paradigm Biocapital Advisors LP is based out at New York, NY

Below you can find more details about Paradigm Biocapital Advisors LP portfolio as well as his latest detailed transactions.

Portfolio value $2.67 Billion
Healthcare: $2.67 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$3.26B
$314 Million 11.77% of portfolio
4,177,830
Q1 2024 Added 8.29%
$2.42B
$266 Million 9.96% of portfolio
3,818,095
Q1 2024 Added 4.36%
$23.8B
$217 Million 8.15% of portfolio
552,120
Q1 2024 Added 30.66%
$2.41B
$146 Million 5.49% of portfolio
3,124,749
Q1 2024 Added 35.1%
$13.8B
$140 Million 5.24% of portfolio
1,078,346
Q1 2024 New
$1.49B
$116 Million 4.36% of portfolio
1,787,176
Q1 2024 Added 22.92%
$7.41B
$111 Million 4.17% of portfolio
1,982,006
Q1 2024 Added 4.61%
$1.42B
$108 Million 4.05% of portfolio
2,614,935
Q1 2024 Added 180.78%
$2.43B
$107 Million 4.01% of portfolio
2,484,874
Q1 2024 Added 16.8%
$725M
$104 Million 3.9% of portfolio
2,863,406
Q1 2024 Added 179.36%
$6.37B
$98.5 Million 3.7% of portfolio
2,330,508
Q4 2023 Reduced 7.99%
$3.4B
$93.9 Million 3.52% of portfolio
2,914,975
Q1 2024 New
$437M
$89.5 Million 3.36% of portfolio
7,903,600
Q4 2023 Added 1.28%
$519M
$88.1 Million 3.3% of portfolio
5,031,420
Q1 2024 Added 4.94%
$4.48B
$84.7 Million 3.18% of portfolio
1,239,995
Q1 2024 New
$0
$84.1 Million 3.15% of portfolio
2,121,163
Q1 2024 Reduced 33.23%
$7.61B
$76.8 Million 2.88% of portfolio
507,952
Q1 2024 Added 44.43%
$1.38B
$66.9 Million 2.51% of portfolio
3,135,387
Q1 2024 Added 148.28%
$1.14B
$44.6 Million 1.67% of portfolio
2,446,373
Q1 2024 New
$316M
$41 Million 1.54% of portfolio
6,425,803
Q1 2024 Reduced 49.05%
$528M
$36.3 Million 1.36% of portfolio
2,233,610
Q1 2024 New
$886M
$29.6 Million 1.11% of portfolio
2,818,908
Q1 2024 Added 31.95%
$3.41B
$25.8 Million 0.97% of portfolio
799,054
Q1 2024 New
$795M
$23 Million 0.86% of portfolio
1,348,015
Q1 2024 New
$363M
$20.4 Million 0.77% of portfolio
2,390,988
Q1 2024 Added 5.52%
$38.1M
$15.3 Million 0.57% of portfolio
6,457,293
Q4 2023 Reduced 0.06%
$233M
$14.9 Million 0.56% of portfolio
944,917
Q1 2024 Added 136.23%
$2.36B
$11.7 Million 0.44% of portfolio
400,000
Q1 2024 New
$99.8M
$11.2 Million 0.42% of portfolio
2,172,620
Q1 2024 Reduced 25.69%
Kyverna Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2024 New
Disc Medicine Inc
-
$0 0.0% of portfolio
-
Q1 2024 Added 0.17%
Cargo Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2024 Reduced 55.61%
Apogee Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2024 New

Summary

  • Portfolio
  • No. of Stocks 34
  • Current Value $2.67 Billion
  • Prior Value $1.93 Billion
  • Filing
  • Period Q1 2024
  • Filing Date May 15, 2024
  • Form Type 13F-HR
  • Activity in Q1 2024
  • New Purchases 10 stocks
  • Additional Purchases 16 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 5 stocks
Track This Portfolio

Track Paradigm Biocapital Advisors LP Portfolio

Follow Paradigm Biocapital Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paradigm Biocapital Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Paradigm Biocapital Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email